# OnCo record paper-eortc-26951-van-den-bent-jco-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-eortc-26951-van-den-bent-jco-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-eortc-26951-van-den-bent-jco-2013" ;
  schema:name "EORTC 26951: adjuvant PCV after radiotherapy for anaplastic oligodendroglial tumours, long-term follow-up"@en ;
  schema:description "This European trial confirmed, independently of the American RTOG 9402 study, that PCV chemotherapy added to radiotherapy lengthens survival in anaplastic oligodendroglioma, with the largest benefit in tumours carrying the 1p/19q codeletion."@en ;
  schema:url <https://onco.cc/key-papers/paper-eortc-26951-van-den-bent-jco-2013/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2012.43.2229>, <https://pubmed.ncbi.nlm.nih.gov/23071237/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2012.43.2229> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "van den Bent MJ, Brandes AA, Taphoorn MJ, et al." ;
  onco:cancers <https://onco.cc/cancers/oligodendroglioma/> ;
  onco:drugs <https://onco.cc/drugs/procarbazine/>, <https://onco.cc/drugs/vincristine/> ;
  onco:trials <https://onco.cc/trials/eortc-26951/>, <https://onco.cc/trials/codel/> ;
  onco:journals <https://onco.cc/journals/jco/> .